Darunavir (Prezista) for HIV infection.
Darunavir (Prezista) for HIV infection. [electronic resource]
- The Medical letter on drugs and therapeutics Sep 2006
- 74-5 p. digital
Publication Type: Journal Article
0025-732X
Antiretroviral Therapy, Highly Active--methods
Biological Availability
Blood Proteins--metabolism
Cytochrome P-450 CYP3A--metabolism
Cytochrome P-450 CYP3A Inhibitors
Darunavir
Drug Approval
Drug Interactions
Drug Resistance, Viral
Enfuvirtide
HIV Envelope Protein gp41--pharmacology
HIV Infections--drug therapy
HIV Protease Inhibitors--pharmacokinetics
HIV-1--drug effects
Humans
Peptide Fragments--pharmacology
Protein Binding--drug effects
RNA, Viral--blood
Randomized Controlled Trials as Topic--methods
Ritonavir--pharmacology
Sulfonamides--pharmacokinetics
Tablets
Time Factors
United States
Viral Load
Publication Type: Journal Article
0025-732X
Antiretroviral Therapy, Highly Active--methods
Biological Availability
Blood Proteins--metabolism
Cytochrome P-450 CYP3A--metabolism
Cytochrome P-450 CYP3A Inhibitors
Darunavir
Drug Approval
Drug Interactions
Drug Resistance, Viral
Enfuvirtide
HIV Envelope Protein gp41--pharmacology
HIV Infections--drug therapy
HIV Protease Inhibitors--pharmacokinetics
HIV-1--drug effects
Humans
Peptide Fragments--pharmacology
Protein Binding--drug effects
RNA, Viral--blood
Randomized Controlled Trials as Topic--methods
Ritonavir--pharmacology
Sulfonamides--pharmacokinetics
Tablets
Time Factors
United States
Viral Load